All these results suggested that the low stability of mdm2 mRNA transcripts upon the lower m6A levels mediated by METTL3- and METTL14-knockdown could lead to the activation of p53 signal pathway, in the end, reverse partially the process of leukemia. Here, MDM2 is linked to leukemia.